The U.S. economic recovery is being threatened by the COVID-19 delta variant. Increasing vaccination rates is the most important thing the U.S. can do to sustain the economy over the next few months. Beyond that, however, full recovery might require creating new vaccines against delta and other emerging variants.
U.S. stock markets and Treasury yields took big dips recently before rebounding. Despite the bounce-back, the volatility is evidence that investors are worried about the health of the recovery. It’s not just markets, either — there are some concrete signs of economic weakness, such as a week with an unexpectedly high number of initial jobless claims. The lights aren’t flashing red yet, but these are clear warning signs.
The obvious reason is the delta variant of COVID-19. This variant, which is both more infectious and more resistant to vaccines than previous versions of the virus, has become the dominant strain in the U.S. As a result, cases are rising again.
The economic risk isn’t a renewed policy of lockdowns and mandatory social distancing; the American populace and government officials seem to have had their fill of such restrictive measures. But in fact, lockdowns were never a big contributor to the economic devastation of 2020. Evidence on the timing and the strictness of government-mandated social distancing measures has shown that economic harm occurred regardless. Nor did state-level reopenings give economies much of a boost.
Vital role of vaccines
But if lockdowns weren’t what hurt the economy, what was it? It was simply widespread fear of the virus. The existence of a deadly, highly contagious plague is a powerful reason to order from Amazon.com instead of going to a store, or to dine at home instead of going to a restaurant. Some people went out, heedless of the danger, but that paltry demand wasn’t enough to sustain local service businesses, which laid off workers.
It was only after vaccines became widely available that local economies really began to roar back to life.
Delta puts that rapid recovery under threat. Its high infectiousness means that even a fairly substantial percent of vaccinated Americans won’t be enough to protect the unvaccinated from getting the virus. And America has quite a lot of unvaccinated people, thanks in part to a right-wing campaign against the (safe and highly effective) vaccines. While some of those unvaccinated Americans will doubtless be as macho in their defiance of delta as they were with the original version of the coronavirus, some will deem it more prudent to avoid crowded indoor spaces just a little bit more.
Meanwhile, even vaccinated Americans may be hesitant to go out in the face of delta. Vaccines significantly lower the risk of becoming infected with delta, and in the vast majority of cases they prevent the vaccinated from getting sick enough to be hospitalized or die. But they don’t entirely eliminate the risks — there’s a fairly substantial number of “breakthrough” infections, even among the fully vaccinated. While that’s rarely life-threatening, there remains the possibility of the protracted symptoms called “long COVID,” even among young people.
Perhaps if this were March 2020, this level of risk wouldn’t be enough to deter Americans from going out to eat and shop. But they’ve had a year to adapt to the habits of social distancing, and many may just decide to extend their pandemic life a little while longer until the threat of delta has passed. To monitor whether this is happening, keep an eye on OpenTable restaurant reservation data. So far it doesn’t look too bad, but if that changes, watch out.
What can anyone do to allay this possibility? As before, only defeating the virus through more comprehensive vaccination will bring the economy fully, reliably back. We need an intensified public information campaign — including the right-wing media — to make that happen.
But in the longer term, confidence might improve with rapid government approval of vaccine boosters specifically designed for delta and other variants that may now be emerging. Ultimately, it may take several iterations of vaccination to clean COVID out of the U.S. economy.
Noah Smith is a Bloomberg Opinion columnist. He was an assistant professor of finance at Stony Brook University.
